MiNA Therapeutics
0 followers
Harnessing an innate mechanism of gene activation, MiNA Therapeutics' platform enables the development of new medicines that restore normal function to patients’ cells. We are applying our technology and clinical know-how to transform the therapy landscape of severe liver and other diseases.
Org chart
Robert Habib Mba
Collapse
Troels Koch
CTO
Robin Wright
Chief Financial Officer
Peter Bains
Chief Business Officer
Bríd Ryan
SVP, Research
